Evonik strengthens biotechnology capabilities for drug substance manufacturing with new investment in Slovakia

Evonik is investing around EUR 80 million to expand its biotechnology capabilities at its Fermas site in Slovenská Ľupča, Slovakia. The investment will add state-of-the-art downstream fermentation technology to support the contract manufacturing services of the group’s drug substance business. The e...